Publication Detail

Citation : Shikuma CM, Bennett K, Ananworanich J, Gerschenson M, Teeratakulpisarn N, Jadwattanakul T, DeGruttola V, McArthur JC, Ebenezer G, Chomchey N, Praihirunkit P, Hongchookiat P, Mathajittiphun P, Nakamoto B, Hauer P, Phanuphak P, Phanuphak N. (2015)
Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.
J Neurovirol 21(5):525-34.
Abstract : Distal leg epidermal nerve fiber density (ENFD) is a validated predictor of HIV sensory neuropathy (SN) risk. We assessed how ENFD is impacted by initiation of first-time antiretroviral therapy (ART) in subjects free of neuropathy and how it is altered when mitochondrial toxic nucleoside medications are used as part of ART. Serial changes in proximal thigh and distal leg ENFD were examined over 72 weeks in 150 Thai subjects randomized to a regimen of stavudine (d4T) switching to zidovudine (ZDV) at 24 weeks vs ZDV vs tenofovir (TDF) for the entire duration of study, all given in combination with nevirapine. We found individual variations in ENFD change, with almost equal number of subjects who decreased or increased their distal leg ENFD over 72 weeks and no relationship to nucleoside backbone or to development of neuropathic signs or symptoms. Lower baseline distal leg ENFD and greater increases in mitochondrial oxidative phosphorylation complex I (CI) activity were associated with larger increases in distal leg ENFD over 72 weeks. Distal leg ENFD correlated with body composition parameters (body surface area, body mass index, height) as well as with blood pressure measurements. Assessed together with a companion cross-sectional study, we found that mean distal leg ENFD in all HIV+ subjects was lower than in HIV- subjects but similar among HIV+ groups whether ART-na�¯ve or on d4T with/without neuropathy/neuropathic symptoms. The utility of ENFD as a useful predictor of small unmyelinated nerve fiber damage and neuropathy risk in HIV may be limited in certain populations.
URL Link : http://www.ncbi.nlm.nih.gov/pubmed/26002840
PMID : 26002840
PMCID : PMC4611029
News
01 October 2018:
Ola HAWAII Team-Science Pilot Projects Program 2019 Call for Abstracts

Ola HAWAII

Team-Science Pilot Projects Program

2019 Call for Abstracts

NIH/NIMHD U54MD007601

We are pleased to announce an opportunity for…

13 September 2018:
Advance to Funding (ATF) Mock Study Section

The Mountain West CTR-IN offers researchers with faculty appointments at our partner institutions the opportunity to have an NIH Study Section-like ex…

23 July 2018:
2018 Health Disparities Research Institute

Apply Now to the 2018 Health Disparities Research Institute!

The National Institute on Minority Health and Health Disparities (NIMHD) will host the…


View more news...


Seminars & Events
18 October 2018, 11:00am - 2:00pm:
Data Security & Privacy
06 September 2018, 11:30am - 1:00pm:
Ola HAWAII Forum - Brown Bag Session
18 April 2018, 8am:
ANNUAL BIOMEDICAL SCIENCES and HEALTH DISPARITIES SYMPOSIUM

View more seminars & events...

Supported by a grant from the National Institute on Minority Health and Health Disparities (U54MD007584), National Institutes of Health.